#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16372	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2088	776.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1418	1418	C	962	C	897	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29978	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3654	817.6	0	.	n	.	0	T695C	SNP	695	695	T	1091	1091	C	925	C,T	876,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29978	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3654	817.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1733	1733	A	1014	A,G	949,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29978	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3654	817.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2367	2367	C	901	C	853	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29978	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3654	817.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2441	2441	A	953	A	918	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29978	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3654	817.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2993	2993	C	966	C,T	915,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	2258	folP	855	855	100.0	folP.l15.c4.ctg.1	1542	145.5	1	SNP	p	R229S	0	.	.	685	687	CGC	1066	1068	CGC	227;226;232	C;G;C	209;208;212	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5906	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3424	171.9	1	SNP	p	S91F	0	.	.	271	273	TCC	637	639	TCC	205;204;202	T;C,T;C	193;194,1;193	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5906	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3424	171.9	1	SNP	p	D95G	0	.	.	283	285	GAC	649	651	GAC	202;201;200	G;A;C	187;186;189	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5906	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3424	171.9	1	SNP	p	D95N	0	.	.	283	285	GAC	649	651	GAC	202;201;200	G;A;C	187;186;189	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	1802	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1397	128.4	1	SNP	p	G45D	1	.	.	133	135	GAC	506	508	GAC	202;201;201	G;A;C	190;188;189	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	982	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c30.ctg.1	1113	87.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5484	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2836	192.2	1	SNP	p	D86N	0	.	.	256	258	GAC	523	525	GAC	239;239;238	G;A;C	225;222;227	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5484	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2836	192.2	1	SNP	p	S88P	0	.	.	262	264	TCC	529	531	TCC	240;239;239	T;C;C	228;229;226	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4382	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2693	161.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1570	1572	GGC	231;229;225	G;G;C	214;211;202	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	4234	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2478	170.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1208	1210	GCA	238;238;237	G;C;A	220;222;220	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4234	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2478	170.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1211	1213	ATC	233;232;235	A;T;C	218;212;219	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4234	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2478	170.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1223	1225	GTG	223;223;220	G;T;G	209;203;204	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4234	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2478	170.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1223	1225	GTG	223;223;220	G;T;G	209;203;204	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4234	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2478	170.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1727	1729	ACC	198;199;198	A;C;C	185;189;188	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4234	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2478	170.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1781	1783	GCG	194;196;196	G;C,G;G	169;145,2;160	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4234	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2478	170.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1781	1783	GCG	194;196;196	G;C,G;G	169;145,2;160	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4234	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2478	170.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1904	1906	GGC	192;193;192	G;G;C	183;182;183	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4234	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2478	170.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1913	1915	GGC	191;188;189	G;G;C,A	177;175;174,1	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4234	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2478	170.2	1	SNP	p	L552S	0	.	.	1654	1656	CTG	1931	1933	CTG	168;169;168	C,G;T;G	120,7;111;126	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	6032	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3156	190.5	1	SNP	p	L421P	1	L421P	NONSYN	1261	1263	CTG	1626	1628	CCG	235;233;230	C;C;G	200;209;202	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2356	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1829	127.7	0	.	p	.	0	S22G	NONSYN	64	66	AGC	408	410	GGC	125;124;125	G;G;C	121;120;121	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2356	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1829	127.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	590	590	C	154	C	149	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3110	porB1b	1047	1047	96.96	porB1b.l15.c17.ctg.1	1606	192.0	0	.	p	.	0	G38E	NONSYN	112	114	GGA	406	408	GAA	271;274;274	G;A;A	262;261;259	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3110	porB1b	1047	1047	96.96	porB1b.l15.c17.ctg.1	1606	192.0	0	.	p	.	0	K120N	NONSYN	358	360	AAG	652	654	AAC	249;249;249	A;A;C	237;236;238	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3110	porB1b	1047	1047	96.96	porB1b.l15.c17.ctg.1	1606	192.0	0	.	p	.	0	G140K	NONSYN	418	420	GGA	712	714	AAA	231;232;234	A,G;A,G;A	223,1;225,1;223	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3110	porB1b	1047	1047	96.96	porB1b.l15.c17.ctg.1	1606	192.0	0	.	p	.	0	K143E	NONSYN	427	429	AAA	721	723	GAA	234;237;236	G,T,C;A;A	221,1,1;223;222	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3110	porB1b	1047	1047	96.96	porB1b.l15.c17.ctg.1	1606	192.0	0	.	p	.	0	Q187R	NONSYN	559	561	CAA	853	855	CGA	287;286;287	C,G;G;A	268,1;268;268	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3110	porB1b	1047	1047	96.96	porB1b.l15.c17.ctg.1	1606	192.0	0	.	p	.	0	S189G	NONSYN	565	567	AGC	859	861	GGC	283;283;284	G,A;G,A;C	262,1;264,1;265	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3110	porB1b	1047	1047	96.96	porB1b.l15.c17.ctg.1	1606	192.0	0	.	p	.	0	N212D	NONSYN	634	636	AAT	928	930	GAT	261;259;258	G;A;T	251;248;242	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3110	porB1b	1047	1047	96.96	porB1b.l15.c17.ctg.1	1606	192.0	0	.	p	.	0	D213N	NONSYN	637	639	GAT	931	933	AAT	257;257;260	A;A;T	248;248;246	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3110	porB1b	1047	1047	96.96	porB1b.l15.c17.ctg.1	1606	192.0	0	.	p	.	0	T215S	NONSYN	643	645	ACT	937	939	TCT	257;261;260	T;C,T;T	243;244,1;246	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3110	porB1b	1047	1047	96.96	porB1b.l15.c17.ctg.1	1606	192.0	0	.	p	.	0	G255Q	NONSYN	763	765	GGA	1057	1059	CAA	211;211;209	C;A;A	203;205;201	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3110	porB1b	1047	1047	96.96	porB1b.l15.c17.ctg.1	1606	192.0	0	.	p	.	0	.	INDELS	766	768	ACA	1061	1065	ATCAA	210;209;210;210;208	A;T;C;A;A	202;200;203;203;199	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3110	porB1b	1047	1047	96.96	porB1b.l15.c17.ctg.1	1606	192.0	0	.	p	.	0	.	INDELS	769	770	TG	1068	1070	AGT	209;204;205	A;G;T	200;196;197	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3110	porB1b	1047	1047	96.96	porB1b.l15.c17.ctg.1	1606	192.0	0	.	p	.	0	A259D	NONSYN	775	777	GCT	1075	1077	GAT	204;203;206	G;A;T	195;192;198	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3110	porB1b	1047	1047	96.96	porB1b.l15.c17.ctg.1	1606	192.0	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1135	1137	GTA	206;208;206	G;T;A	195;197;192	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3110	porB1b	1047	1047	96.96	porB1b.l15.c17.ctg.1	1606	192.0	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1180	1182	GAT	205;207;208	G,T;A;T	185,1;191;191	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3110	porB1b	1047	1047	96.96	porB1b.l15.c17.ctg.1	1606	192.0	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1189	1191	AAC	214;217;215	A;A;C	198;199;196	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3110	porB1b	1047	1047	96.96	porB1b.l15.c17.ctg.1	1606	192.0	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1192	1194	CAC	216;214;214	C;A,T;C	199;197,1;201	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	539	11718	rpoB	4179	4179	99.95	rpoB.l15.c4.ctg.1	4749	245.3	0	.	p	.	0	R201H	NONSYN	601	603	CGT	846	848	CAT	266;267;268	C;A;T	253;252;255	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1250	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1154	107.8	1	SNP	p	V57M	1	.	.	169	171	ATG	534	536	ATG	242;242;244	A;T;G	234;233;234	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
